Vascular Immunotargeting: Take the Highway to the First Exit

Overview

Journal Hepatology

Specialty Gastroenterology

Date 2018 Aug 3

PMID 30070712

Citations 3

Authors

Vladimir R Muzykantov

Jacob S Brenner

Affiliations

Soon will be listed here.

Citing Articles

Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines.

Tang Y, Yu Z, Lu X, Fan Q, Huang W Adv Sci (Weinh). 2022; 9(13):e2103148.

PMID: 35246962 PMC: 9069202. DOI: 10.1002/advs.202103148.

Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.

Glassman P, Hood E, Ferguson L, Zhao Z, Siegel D, Mitragotri S Adv Drug Deliv Rev. 2021; 178:113992.

PMID: 34597748 PMC: 8556370. DOI: 10.1016/j.addr.2021.113992.

Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia.

Okay M, Cetik S, Haznedaroglu I Turk J Haematol. 2019; 36(3):218-219.

PMID: 31067853 PMC: 6682773. DOI: 10.4274/tjh.galenos.2019.2019.0113.

References

Murciano J, HARSHAW D, Ghitescu L, Danilov S, Muzykantov V . Vascular immunotargeting to endothelial surface in a specific macrodomain in alveolar capillaries. Am J Respir Crit Care Med. 2001; 164(7):1295-302. DOI: 10.1164/ajrccm.164.7.2010076. View

McIntosh D, Tan X, Oh P, Schnitzer J . Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A. 2002; 99(4):1996-2001. PMC: 122308. DOI: 10.1073/pnas.251662398. View

Scherpereel A, Rome J, Wiewrodt R, Watkins S, Harshaw D, Alder S . Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature. J Pharmacol Exp Ther. 2002; 300(3):777-86. DOI: 10.1124/jpet.300.3.777. View

Danielyan K, Ding B, Gottstein C, Cines D, Muzykantov V . Delivery of anti-platelet-endothelial cell adhesion molecule single-chain variable fragment-urokinase fusion protein to the cerebral vasculature lyses arterial clots and attenuates postischemic brain edema. J Pharmacol Exp Ther. 2007; 321(3):947-52. DOI: 10.1124/jpet.107.120535. View

Preissler G, Loehe F, Huff I, Ebersberger U, Shuvaev V, Bittmann I . Targeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac death. Transplantation. 2011; 92(4):380-7. PMC: 5505068. DOI: 10.1097/TP.0b013e318226bc6b. View

Gustafson H, Holt-Casper D, Grainger D, Ghandehari H . Nanoparticle Uptake: The Phagocyte Problem. Nano Today. 2015; 10(4):487-510. PMC: 4666556. DOI: 10.1016/j.nantod.2015.06.006. View

Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D . Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol. 2016; 66(1):212-227. DOI: 10.1016/j.jhep.2016.07.009. View

Tietjen G, Hosgood S, DiRito J, Cui J, Deep D, Song E . Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys. Sci Transl Med. 2017; 9(418). PMC: 5931373. DOI: 10.1126/scitranslmed.aam6764. View

Winkler N, Strubing F, Gross W, Mier W, Ryschich E . Phenomenon of Endothelial Antibody Capture: Principles and Potential for Locoregional Targeting of Hepatic Tumors. Hepatology. 2018; 68(5):1804-1816. DOI: 10.1002/hep.30072. View

10.

Pasqualini R, Ruoslahti E . Organ targeting in vivo using phage display peptide libraries. Nature. 1996; 380(6572):364-6. DOI: 10.1038/380364a0. View

11.

Muzykantov V, Barnathan E, Atochina E, Kuo A, Danilov S, Fisher A . Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature. J Pharmacol Exp Ther. 1996; 279(2):1026-34. View